ArticleBlood advances2019

RUNX1 mutations enhance self-renewal and block granulocytic differentiation in human in vitro models and primary AMLs.

Mylène Gerritsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.